G2083 is one of 3 ways to bill Medicare for Spravato
Medicare's 2026 national rate for G2083, the code for doses above 56 mg, is $1,152.67 for a nurse practitioner, 85% of the physician rate of $1,356.08.
Head of Growth and Operations, JotPsych
When your patient's Spravato dose moves from 56 mg to 84 mg, the visit takes three nasal spray devices instead of two. Check two facts first. The dose and who supplies the drug decide the way to bill.
| Way to bill | When to use | Nurse practitioner national rate, 2026 |
|---|---|---|
| Office visit plus prolonged service codes | Your practice observes the patient but doesn't supply the drug | Set by the codes billed |
| G2082 | Your practice supplies up to 56 mg | $809.70 |
| G2083 | Your practice supplies above 56 mg | $1,152.67 |
Under Medicare's 2019 rule, G2082 and G2083 each bundle the drug, the visit, and the observation into one rate. An 84 mg dose your practice supplies takes G2083.
Office visit plus prolonged service codes
Bill an office visit plus prolonged service codes when your practice observes your patient but doesn't supply the drug. Medicare's 2019 rule says a provider then "cannot report" G2082 or G2083.
Your clinical staff's observation time takes 99415 once it runs 30 minutes past the visit's typical staff time. With a 99214, that typical time is 40 minutes. So 99415 starts at 70 minutes of your staff's time, and 99416, which covers each added 30 minutes, starts at 115.
Your own time takes G2212, Medicare's prolonged service code. Add G2212 to a 99215 billed by time once your total reaches 69 minutes, but you can't bill G2212 on the same date as 99415 or 99416.
G2082
Each device delivers 28 mg, according to the Food and Drug Administration (FDA) label, so two devices deliver 56 mg, the most G2082 covers. For that visit, Medicare's 2026 national rate is $809.70 for a nurse practitioner, 85% of the physician rate of $952.59.
G2083
Three devices deliver 84 mg. The visit moves to G2083. G2083's 2026 national Medicare rate is $1,152.67 for a nurse practitioner and $1,356.08 for a physician. The step up from G2082 is $342.97 for a nurse practitioner and $403.49 for a physician.
Your observation time doesn't change. The FDA label calls for at least 2 hours at each session, whatever the dose, and G2082 and G2083 both include those 2 hours.
Medicare's 2026 national rates pay more for G2083 than for G2082, for a nurse practitioner and for a physician. A dose above 56 mg billed as G2082 loses the difference.
Medicare bases its payment on the lesser of your charge and your local rate, so a G2083 charge below your local rate lowers what you're paid. Pick the way that fits each visit.
Type the dose and device count in the Notepad, and JotPsych writes both into the draft note.
Book 15 minutes- Centers for Medicare & Medicaid Services, PFS Relative Value Files: 2026 national physician rates and short descriptors (such as "Office o/p est mod 30 min") from the October 2026 release (RVU26D), file PPRRVU2026_Oct_nonQPP, conversion factor 33.4009.
- Legal Information Institute, Cornell Law School, 42 U.S.C. 1395l(a)(1)(N) and (O): Medicare pays 80 percent of the lesser of the actual charge and the fee schedule amount for a physician's service, and 80 percent of "the lesser of the actual charge or 85 percent of the fee schedule amount" for a nurse practitioner's, read October 2, 2026.
- Centers for Medicare & Medicaid Services, Calendar Year 2020 Physician Fee Schedule final rule (CMS-1715-F), 84 FR 62568, November 15, 2019, pages 63103 to 63104.
- American Medical Association, CPT Evaluation and Management (E/M) Code and Guideline Changes, effective January 1, 2023: prolonged clinical staff services, 99415 and 99416, and the Reporting Prolonged Clinical Staff Time table.
- Centers for Medicare & Medicaid Services, Medicare Learning Network, Evaluation and Management Services (MLN006764), May 2026.
- U.S. Food and Drug Administration, SPRAVATO (esketamine) nasal spray prescribing information, revised April 2025, sections 2.1 and 2.4.